Internal Medicine, Medical Oncology · Houston, TX
NPI
1003159054
Since 2013
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
529 services
Medicare patients, 2024
170
Average age 73
Drug cost, 2024
$2.4M
376 prescriptions
Company payments, 2025
$3,615
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sunyoung Lee was code 99215 (office e&m - established), 166 times for 92 patients. In total Sunyoung Lee billed 529 services in 17 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 166 | 92 | $110.62 | $18K |
| 99215 Office E&M - Established | Facility | 115 | 70 | $107.76 | $12K |
| 99214 Office E&M - Established | Office | 75 | 35 | $80.24 | $6,018 |
| 99214 Office E&M - Established | Facility | 32 | 19 | $77.41 | $2,477 |
| 99443 Telephone Services | Office | 29 | 24 | $93.64 | $2,716 |
| 99205 Office E&M - New | Facility | 22 | 22 | $133.22 | $2,931 |
| 99442 Telephone Services | Office | 19 | 16 | $65.98 | $1,254 |
| 99222 Hospital E&M - Initial | Facility | 17 | 16 | $104.55 | $1,777 |
| 99497 Care Management/Coordination | Facility | 14 | 13 | $59.87 | $838 |
By year: 2022 $49K for 462 services; 2023 $46K for 462 services; 2024 $52K for 529 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sunyoung Lee prescribed most often to Medicare patients was Lenvima (Lenvatinib Mesylate), with 35 prescriptions and refills. In total Sunyoung Lee wrote 376 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenvima Lenvatinib Mesylate | 35 | 35 | 12 | $800K |
| Furosemide Generic | 32 | 46 | 17 | $76.24 |
| Spironolactone Generic | 27 | 33 | 17 | $212 |
| Pemazyre Pemigatinib | 23 | 23 | Under 11 | $401K |
| Ondansetron Hcl Generic | 21 | 21 | 16 | $141 |
| Cabometyx Cabozantinib S-Malate | 18 | 18 | Under 11 | $746K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 18 | 18 | 13 | $399 |
| Prochlorperazine Maleate Generic | 17 | 17 | 13 | $304 |
| Lytgobi Futibatinib | 16 | 16 | Under 11 | $362K |
| Eliquis Apixaban | 16 | 16 | Under 11 | $8,931 |
| Xifaxan Rifaximin | 11 | 11 | Under 11 | $34K |
Brand drugs: 146 claims; generic drugs: 230 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sunyoung Lee $3,615 ($3,615 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,107.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.